scarletred
Home
Company
Products
Scarletred
®Vision
Scarletred
®Telemedicine
Services
Applications
CAREER
News
Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint
AAD 2023
Keywords:
#
AAD 2024
#
Tissue Classifier
#
Conferences
#
Skin Care
#
BioJapan2022
#
JAK inhibitors
#
Safety monitoring
News
•
Feb 20, 2023
SCARLETRED Joins 2023 AAD Annual Meeting in New Orleans, LA, USA
Our CEO Harald Schnidar is invited to present the results of a cooperation with GALDERMA and the University of Tübingen, wherein Scarletred®Vision confirmed the therapeutic efficacy of Ivermectin in Rosacea patients.
No items found.
Paper
•
November 30, 2023
Automated Classification of Hidradenitis Suppurativa Disease Severity by Convolutional Neural Network Analyses Using Calibrated Clinical Images
Read more